Chronic effects of tramadol hydrochloride/paracetamol oral administration on haematological parameters and glucose level in Wistar rats

Abstract

Tramadol hydrochloride/paracetamol is an opioid that is composed of two different analgesics, tramadol (opioid, 37.5 mg) and paracetamol (non opioid, 325 mg). The study presents first data of tramadol hydrochloride/paracetamol effects on haematological parameters and glucose levels in Wistar rats. Oral administration ad libitum of tramadol hydrochloride/paracetamol was administered during a twenty days period. This research includes two groups of animals. Group I include animals that were administered tramadol hydrochloride/paracetamol daily at dosage of 1.12 g/300 ml and group II that were administered daily at dosage of 1.68 g/300 ml of water. We analayzed 14 haematological parameters and glucose concentration. Significant changes were established for all analyzed parameters. Significantly low numbers of erythrocytes, leukocytes and lymphocytes were observed. Tramadol hydrochloride/paracetamol has an extremely negative effect on haematological parameters in Wistar rats, particularily on the blood coagulation due to the thrombocitopenia, anaemia and weakened immunity. If properly administered, tramadol hydrochloride/paracetamol can be an effective analgesic but at high dosage and over a prolonged period it may cause adverse effects in Wistar rats.

Keywords

• Tramadol hydrochloride/paracetamol
• Wistar rats
• haematological parameters
• glucose

References

1. [1] US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines; requires label changes. https://www.fda.gov/drugs/drug-safety-and-availability/fdadrug-safety-communication-fda-warns-about-several-safety-issues-opioid-pain-medicines-requires (accessed on 22 March 2016).
2. [2] Leppert W. Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol Rep. 2009; 61: 978–992. [CrossRef]
3. [3] Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül Ö, Kozak O, Kurt E, Aypar U. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology. 2010; 112: 696-710. [CrossRef]
4. 4 Kaneko K, Umehara M, Homan T, Okamoto K, Oka M, Oyama T. The analgesic effect of tramadol in animal models of neuropathic pain and fibromyalgia. Neurosci Lett. 2014; 562: 28-33. [CrossRef]
5. 5 Brayfield A. Tramadol hydrochloride. In: BrayfieldA. (Ed). Martindale: The complete drug reference. Pharmaceutical Press, London, 2014, pp.46-88.
6. 6 NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0. Am J Health Syst Pharm. 2016; 73(15): 1144-1165. [CrossRef]
7. 7 Chandanwale AS, Sundar S, Latchoumibady K, Biswas S, Gabhane M, Naik M, Patel K. Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a Phase III, 5-day open-label study. J Pain Res. 2014; 7: 455-463. [CrossRef]
8. 8 Raffa RB, Clark-Vetri R, Tallarida RJ, Wertheimer AI. Combination strategies for pain management. Expert Opinion on Pharmacotherapy. 2003; 4(10): 1697-1708. [CrossRef]

9. 9 Blough ER, Wu M. Acetaminophen: beyond pain and Fever- relieving. Front Pharmacol. 2011; 72(2): 1-6. [CrossRef]
10. 10 Merrill GF, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol. 2001; 96(5): 423-430. [CrossRef]
11. 11 Jaques-Robinson KM, Golfetti R, Baliga SS, Hadzimichalis NM, Merrill GF. Acetaminophen is cardioprotective against H2O2-induced injury in vivo. Exp Biol Med. 2008; 233(10): 1315- 1322. [CrossRef]
12. 12 Tripathy D, Grammas P. Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress. J Neuroinflammation. 2009; 6(10): 1-9. [CrossRef]
13. 13 Bisaglia M, Venezia V, Piccioli P, Stanzione S, Porcile C, Russo C, Mancini F, Milanese C, Schettini G. Acetaminophen protects hippocampal neurons and PC12 cultures from amyliod beta-peptides induced oxidative stress and reduces NF-kappa B activation. Neurochem Int. 2002; 41(1): 43-54. [CrossRef]
14. 14 Vanderah TW. Pathophysiology of pain. Med Clin North Am. 2007; 91(1): 1–12. [CrossRef]
15. 15 Rawal N, Macquaire V, Catalá E, Berti M, Costa R, Wietlisbach M. Tramadol/paracetamol combination tablet for postoperative pain following ambulatory hand surgery: a double-blind, double-dummy, randomized, parallel-group trial. J Pain Res. 2011; 4: 103–110. [CrossRef]
16. 16 Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther. 2001; 26(4): 257– 264. [CrossRef]
17. 17 Filitz J, Ihmsen H, Günther W, Tröster A, Schwilden H, Schüttler J, Koppert W. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain. 2008; 136(3): 262–270. [CrossRef]
18. 18 McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol. 2003; 28: 19–22
19. 19 Thornton JR, Losowsky MS. Severe thrombocytopenia after paracetamol overdose. Gut. 1990; 31(10): 1159-1160. [CrossRef]
20. 20 Waris N, Kausar R, Waris N, Naz F, Raza A. Effect of extra panadol on blood and behavior of rats. J Bioanal Biomed. 2017; 9(4): 206-211. [CrossRef]
21. 21 Cascio MJ, DeLoughery TG. Anemia: evaluation and diagnostic tests. Med Clin North Am. 2017; 101(2): 263-284. [CrossRef]
22. 22 Hossain MS, AminMR, Mostafa M, Hossain MJ, Hasan MM. Effects of oral administration of nonsteroidal antiinflammatory drugs: aspirin and paracetamol in mice. Bangladhes J Agri. 2003; 1(1): 67-70. [CrossRef]
23. 23 Bhaumik A, Sharma MC. Therapeutic efficacy of Liv. 52 in experimentally induced hepatopathy in sheep. J Appl Anim Res. 1993; 3(2): 137-142. [CrossRef]
24. 24 Azeemuddin M, Rafiq M, Anturlikar SD, Sharath Kumar LM, Patki PS, Babu UV, Shyam R. Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis. J Tradit Complement Med. 2016; 6(2): 160–167. [CrossRef]
25. 25 Adams HR, Veterinary pharmacology and therapeutics, Iowa State University Press, Ames, USA 1995, pp.625.
26. 26 Oyedeji KO, Bolarinwa AF, Ojeniran SS. Effect of paracetamol (Acetaminophen) on haematological and reproductive parameters in male Albino rats. J Pharm Biol Sci. 2013; 4(6): 65-70.
27. 27 Sharma MC, Dixit SK, Lal SB, Bhaumik A, Baig J. Effect of a herbal preparation in experimentally induced hepatopathy in goats. Indian J Anim Sci. 1993; 63(6): 606-610.
28. 28 Ramesh N, Jayakumar K, Honnegowda H, Narayana K. Effect of diclofenac and nimesulide on haematology in dogs. Indian J Anim Sci. 2001; 71(3): 221-223.
29. 29 Samuel SA, Francis AO, Ayomide O, Onyinyechi UO. Effects of paracetamol-induced liver damage on some hematological parameters: red blood cell (RBC) count, white blood cell (WBC) count, and packed cell volume (PCV) in Wistar rats of either sex. Indo Am J Pharm Res. 2015; 5(7): 2593-2599.
30. 30 Brander GC, Pugh DM, Bywater RJ, Jenkins WL. Veterinary applied pharmacology and therapeutics, fifth ed., The Bath Press, Avon, UK 1991, pp.140-142.
31. 31 Ekam VS, Ebong PE. Serum protein and enzyme levels in rats following administration of antioxidant vitamins during caffeinated and non-caffeinated paracetamol induced hepatotoxicity. Niger J Physiol Sci. 2007; 22(1-2): 65-68. [CrossRef]
32. 32 Adedapo AA, Abatan MO, Olorunsogo OO. Effects of some plants of the spurge family on haematological and biochemical parameters in rats. Veterinarski Arhiv. 2007; 77(1): 29-38.
33. 33 Elyazji NR, Abdel-Aziz I, Aldalou A, Shahwan O. The efects of Tramadol Hydrochloride administration on the hematological and biochemical profiles of domestic male rabbits. J Natural Engineering Studies. 2013; 21(2): 51-65.
34. 34 Molina PE. Opioids and opiates: analgesia with cardiovacular haemodynamic and immune implications en critical illness. J Intern Med. 2006; 259(2): 138-154. [CrossRef]
35. 35 Lamont LA, Mathews KA., Opioids, nonsteriodal anti-inflammatories and analgesic adjuvants. In: TranquilliJt, Thurmon JC, Grimm KA. (Eds). Lumb and Jones’Veterinary anesthesia and analgesia. Blackwell Publising Oxford, USA, 2007, pp.241-271.
36. 36 Elmanama AA, Abu Tayyem NES, Essawaf HN, Hmaid IM. Tramadol induced liver and kidney toxicity among Abusers in Gaza Strip, Palestine. Jordan J Biol Sci. 2015; 8(2): 133-137.
37. 37 Bishop LM, Fody PE, Schoe HL. Clinical chemistry principles, procedures correlations. Lippinoch Williams and Wilkins, Philadelphia, Hong Kong, 2005, pp.253-330.
38. 38 Aldiwan MA, Hassan Alzobidy AM, Younis MA. The effect of tramadol on some blood and biochemical parameters of male rats (Rattus norvegicus). Baghdad Sci J. 2015; 12(3): 496-502.
39. 39 Juei-Tang C, Liu IM, Tzong-Cherng C, Thing-Fong T, Feng-Hwa L, Chih Jen C. Plasma glucose lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 2001; 50(12): 2815-2821. [CrossRef]
40. 40 Peyriêre H, Villiet M, Albert V,Creus M. Hypoglycemia related to tramadol therapy. French Pharmacol. 2004; 18(2): 215-268.
41. 41 Goeringer KE, Logan BK, Christian GD. Identification of tramadol and its metabolite in blood from drug-related death and drug-impaired-drivers. J Anal Toxicol. 1997; 21(7): 529-537. [CrossRef]
42. 42 Hamad AA, Torad FA, Thabet NS, Gadallah SM. Effect of tramadol versus fentanyl on some hematological and serum biochemical parameters in dogs. Alexandria J Vet Sci. 2016; 50(1): 122-129. [CrossRef]
43. 43 Costa PF, Nunes N, Belmonte EA, Moro JV, Lopes PCF. Hematologic changes in propofol-anesthetized dogs with or without tramadol administration. Arq Bras Med Vet Zootec. 2013; 65(5): 1306-1312. [CrossRef]
44. 44 Sheng J, Hong-Gang, De-Zhang L, Jin-Long H, Xu-Dong S, Yue W, Hong-Bin W. Effects of the tiletamine/zolazepamxylazine-tramadol combination on plasma oxidative status and haematological indicators in miniature pigs. Acta Vet Brno. 2014; 83: 145–149. [CrossRef]
45. 45 Teixeira LG, Martins LR, Schimites PI, Dornelles GL, Aiello G, Oliveira JS, da Silva FC, Brum BT, Walter TM, Andrade CM, Soares AV. Evaluation of postoperative pain and toxicological aspects of the use of dipyrone and tramadol in cats. J Feline Med Surg. 2019; 21(5): 1-9. [CrossRef]